Featuring perspectives from Dr Stephen Ansell, including the following topics:
- Evolution of first-line management of advanced Hodgkin lymphoma (HL) (0:00)
- Transplant strategies and outcomes for patients with relapsed/refractory HL (4:20)
- Chemoimmunotherapy options for patients with HL (8:06)
- Current and future management of limited-stage disease (11:52)
- Addition of antibody-drug conjugates to HL treatment strategies (22:52)
- Long-term management of HL (29:16)
- Future management of HL — novel agents and strategies (34:56)
CME information and select publications